These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

840 related items for PubMed ID: 16773209

  • 1. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y.
    Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
    [Abstract] [Full Text] [Related]

  • 2. Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.
    Pick A, Wiese M.
    ChemMedChem; 2012 Apr; 7(4):650-62. PubMed ID: 22354538
    [Abstract] [Full Text] [Related]

  • 3. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y, Chen X, Luo Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [Abstract] [Full Text] [Related]

  • 4. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF, Ross AR, Arnason TG, Juurlink BH, Harkness TA.
    Cancer Lett; 2010 Feb 28; 288(2):236-50. PubMed ID: 19699029
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells.
    Yu XD, Wang SY, Chen GA, Hou CM, Zhao M, Hong JA, Nguyen DM, Schrump DS.
    Cancer J; 2007 Feb 28; 13(2):105-13. PubMed ID: 17476138
    [Abstract] [Full Text] [Related]

  • 6. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
    Zhang XJ, Zhang L, Liu YP, Xu HM, Sun P, Song JG, Luo YH.
    Zhonghua Zhong Liu Za Zhi; 2013 Mar 28; 35(3):181-6. PubMed ID: 23879997
    [Abstract] [Full Text] [Related]

  • 7. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
    Whitley BR, Beaulieu LM, Carter JC, Church FC.
    Gynecol Oncol; 2007 Feb 28; 104(2):470-9. PubMed ID: 17070899
    [Abstract] [Full Text] [Related]

  • 8. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S.
    Int J Cancer; 2007 Oct 01; 121(7):1424-32. PubMed ID: 17551921
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation.
    Sun DF, Zhang YJ, Tian XQ, Chen YX, Fang JY.
    Cell Biol Int; 2014 Jan 01; 38(1):50-63. PubMed ID: 24030871
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of EGFR/AKT signaling enhances TSA-induced ovarian cancer cell differentiation.
    Shao G, Lai W, Wan X, Xue J, Wei Y, Jin J, Zhang L, Lin Q, Shao Q, Zou S.
    Oncol Rep; 2017 May 01; 37(5):2891-2896. PubMed ID: 28393191
    [Abstract] [Full Text] [Related]

  • 11. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
    Liu X, Carlisle DL, Swick MC, Gaither-Davis A, Grandis JR, Siegfried JM.
    Exp Cell Res; 2007 Apr 15; 313(7):1361-72. PubMed ID: 17349623
    [Abstract] [Full Text] [Related]

  • 12. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells.
    Jiang Q, Zhou C, Bi Z, Wan Y.
    J Ocul Pharmacol Ther; 2006 Apr 15; 22(2):93-102. PubMed ID: 16722795
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S, Hussain AR, Al-Hussein KA, Manogaran PS, Wickrema A, Gutierrez MI, Bhatia KG.
    Clin Cancer Res; 2005 Apr 15; 11(8):3102-8. PubMed ID: 15837766
    [Abstract] [Full Text] [Related]

  • 14. Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells.
    An X, Wei Z, Ran B, Tian H, Gu H, Liu Y, Cui H, Zhu S.
    Anticancer Agents Med Chem; 2020 Apr 15; 20(17):2114-2124. PubMed ID: 32593284
    [Abstract] [Full Text] [Related]

  • 15. Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.
    Qiu L, Di W, Jiang Q, Scheffler E, Derby S, Yang J, Kouttab N, Wanebo H, Yan B, Wan Y.
    Int J Oncol; 2005 Nov 15; 27(5):1441-8. PubMed ID: 16211241
    [Abstract] [Full Text] [Related]

  • 16. [High D-glucose alters PI3K and Akt signaling and leads to endothelial cell migration, proliferation and angiogenesis dysfunction].
    Yu P, Yu DM, Qi JC, Wang J, Zhang QM, Zhang JY, Tang YZ, Xing QL, Li MZ.
    Zhonghua Yi Xue Za Zhi; 2006 Dec 26; 86(48):3425-30. PubMed ID: 17313857
    [Abstract] [Full Text] [Related]

  • 17. Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.
    Chao H, Wang L, Hao J, Ni J, Chang L, Graham PH, Kearsley JH, Li Y.
    Cancer Lett; 2013 Feb 01; 329(1):17-26. PubMed ID: 22995071
    [Abstract] [Full Text] [Related]

  • 18. Lipopolysaccharide induces VCAM-1 expression and neutrophil adhesion to human tracheal smooth muscle cells: involvement of Src/EGFR/PI3-K/Akt pathway.
    Lin WN, Luo SF, Wu CB, Lin CC, Yang CM.
    Toxicol Appl Pharmacol; 2008 Apr 15; 228(2):256-68. PubMed ID: 18182168
    [Abstract] [Full Text] [Related]

  • 19. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C, Liu VW, Chan DW, Yao KM, Ngan HY.
    Int J Gynecol Cancer; 2012 Jan 15; 22(1):15-22. PubMed ID: 22080879
    [Abstract] [Full Text] [Related]

  • 20. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
    Badinloo M, Esmaeili-Mahani S.
    Fundam Clin Pharmacol; 2014 Aug 15; 28(4):414-22. PubMed ID: 23837575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.